scholarly journals The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: An exploratory study

Cytokine ◽  
2014 ◽  
Vol 69 (1) ◽  
pp. 110-115 ◽  
Author(s):  
D.S. Pisetsky ◽  
S.E. Trace ◽  
K.A. Brownley ◽  
R.M. Hamer ◽  
N.L. Zucker ◽  
...  
2017 ◽  
Vol 4 (1) ◽  
pp. 57-59
Author(s):  
S. Dhungana ◽  
S.P. Ojha ◽  
M. Chapagai ◽  
P. Tulachan

Anorexia nervosa is a syndrome characterized by severe weight loss and preoccupation of distorted body image with resulting complications due to starvation. In most of the typical cases of anorexia nervosa, neuroimaging is not done. However, with increasing evidence of intracranial lesions associated with eating disorders including anorexia nervosa, neuroimaging is indicated in almost all cases. We present a case of a 17-year-old female who was admitted initially with the diagnosis of anorexia nervosa (restricting type) and later found to have pituitary adenoma.


1993 ◽  
Vol 162 (4) ◽  
pp. 452-462 ◽  
Author(s):  
C. W. Sharp ◽  
C. P. L. Freeman

The physical complications of anorexia nervosa are common and can be life threatening, but psychiatrists and the increasing number of non-medical therapists involved in treatment programmes often overlook these complications. Cardiovascular complications are the most common, and the most likely to result in fatalities, particularly in those patients who vomit, purge or abuse diuretics, because of the electrolyte abnormalities induced. Osteoporosis is an early and perhaps irreversible consequence of severe weight loss. Further, there are dangers in rapid intravenous hyperalimentation.


2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Ken Kurisu ◽  
Yukari Yamanaka ◽  
Tadahiro Yamazaki ◽  
Ryo Yoneda ◽  
Makoto Otani ◽  
...  

Abstract Background Superior mesenteric artery (SMA) syndrome is a well-known but relatively rare complication of anorexia nervosa. Although several reports have proposed surgery for SMA syndrome associated with anorexia nervosa, these have shown poor outcomes or did not reveal the long-term weight course. Thus, the long-term effectiveness of surgery for SMA syndrome in such cases remains unclear. This case report describes a patient with anorexia nervosa who underwent surgery for SMA syndrome. Case presentation An 18-year-old woman presented with anorexia nervosa when she was 16 years old. She also presented with SMA syndrome, which seemed to be caused by weight loss due to the eating disorder. Nutrition therapy initially improved her body weight, but she ceased treatment. She reported that symptoms related to SMA syndrome had led to her weight loss and desired to undergo surgery. Laparoscopic duodenojejunostomy was performed, but her body weight did not improve after the surgery. The patient eventually received conservative nutritional treatment along with psychological approaches, which led to an improvement in her body weight. Conclusions The case implies that surgery for SMA syndrome in patients with anorexia nervosa is ineffective for long-term weight recovery and that conservative treatment can sufficiently improve body weight; this is consistent with the lack of evidence on the topic and reports on potential complications of surgery. Due to difficulties in assessing psychological status, consultation with specialists on eating disorders is necessary for treating patients with severely low body weight.


2018 ◽  
Vol 9 (6) ◽  
pp. 1079-1092 ◽  
Author(s):  
Lena Pinzur ◽  
Levent Akyuez ◽  
Lilia Levdansky ◽  
Michal Blumenfeld ◽  
Evgenia Volinsky ◽  
...  

Author(s):  
Headland ◽  
Clifton ◽  
Keogh

Fibroblast growth factor-21 (FGF-21), is a protein involved in cell growth and differentiation, development, wound repair and metabolism. Research looking at the impact of weight loss on FGF-21 levels is limited. The objective of this exploratory study was to determine changes in serum FGF-21 levels following weight loss induced by either continuous energy restriction or intermittent energy restriction. A sub cohort of participants who completed a 12-month dietary intervention trial following continuous energy restriction, or a week-on week-off energy restriction pattern, were selected for analysis. FGF-21 levels were not altered by weight loss and were not correlated with body weight or BMI at baseline or 12 months. Weight loss after 12 months either through continuous energy restriction or intermittent energy restriction was −5.9 ± 4.5 and −4.9 ± 3.4 kg, respectively. There was no change in FGF-21 levels, 0.3 ± 0.9 and 0.04 ± 0.2 ng/mL (p = 0.2). In conclusion, weight loss in healthy overweight or obesity subjects did not affect FGF-21 levels.


2017 ◽  
Vol 5 (10) ◽  
pp. e150 ◽  
Author(s):  
Elizabeth Victoria Eikey ◽  
Madhu C Reddy ◽  
Kayla M Booth ◽  
Lynette Kvasny ◽  
Johnna L Blair ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document